Octapharma are the world’s largest privately owned plasma fractionator, with over 40 years of experience in the industry. Octapharma produce a range of GMP grade plasma derived proteins and serum media additives for the Life Sciences sector. Suitable for Cell & Gene Therapy, Vaccine Development, RNA/DNA Therapeutics, In Vitro Diagnostics, Immunoassays, and wider CDMO/CRO/CMO usage. All proteins are GMP grade, produced to a medicinal standard, and double-pathogen reduced. Bespoke and tailored regulatory documents can also be supplied to support approval body submission where material is listed as an excipient. With several concentrations available for each product, we can confidently support small-scale laboratory use, right through to end product manufacture, supporting all paces of company scale-up.
